Supio Review 2026: Features, Pricing & Verdict

What is Supio?

Supio is an AI platform built for one kind of customer: the plaintiff law firm. Where general legal AI assistants such as Harvey aim at the broad research-and-drafting needs of large firms and corporate legal departments, Supio goes narrow and deep into personal-injury and mass-tort practice — the world of medical records by the banker’s box, demand letters that determine settlement value, lien ledgers, treatment gaps and deposition transcripts. The company describes itself as “the first end-to-end agentic AI platform built exclusively for plaintiff law,” and the product line backs the claim: intake, medical chronologies, demand generation, case economics, litigation drafting and firm-level analytics all live in one system rather than a chain of point tools.

The core mechanic is document intelligence at case scale. Supio ingests the complete file — medical records, bills, police reports, intake notes, correspondence — and builds a structured picture of the case: what happened, what treatment followed, what it cost, and where the gaps and inconsistencies are. Its outputs are source-linked; the vendor’s consistent pitch is that every fact in a chronology or demand traces back to a specific page of the underlying record, so an attorney can verify any claim before standing behind it. Supio pairs that with what it calls human expert verification — people, not just models, checking output accuracy — which the company credits for its traction in a practice area where a hallucinated medical fact is not an inconvenience but a malpractice risk.

Supio is a Seattle company. It emerged from stealth in August 2024 with a $25 million Series A, then raised a $60 million Series B in April 2025 led by Sapphire Ventures with participation from Mayfield and Thomson Reuters Ventures, bringing total funding to $91 million. Co-founder Jerry Zhou is CEO. The Thomson Reuters investment matters beyond the money: it underpins a product-level connection to Westlaw that Supio now treats as a headline differentiator.

Where Supio fits in the 2026 legal AI market

The legal AI market in 2026 has split into layers. At the top sit generalist platforms — Harvey, CoCounsel, Legora — selling research, review and drafting to large firms and in-house teams. Below them, vertical specialists own a single practice area, and plaintiff personal-injury law has become the most contested vertical of all, because the work is document-crushing, high-volume and directly tied to settlement economics. Supio’s main rival there is EvenUp, which built the category around AI demand packages; other neighbors include contract-focused tools like Spellbook and document-review platforms like Luminance, which serve different legal jobs entirely. Supio’s bet is that PI firms do not want another task tool — they want one platform that carries the case from intake to verdict and gets smarter with every matter the firm runs through it.

Supio pricing in 2026

Supio does not publish pricing. There is no pricing page, no self-serve tier and no rate card anywhere on supio.com; the site’s only commercial call to action is “Book a Demo.” Every engagement is scoped and quoted by sales, and based on how the product is packaged — separate products for intake, chronologies, demands, case economics and drafting, plus the firm-wide Supio Agent layer and integrations — a quote will depend on which modules you take, your caseload volume and the systems you connect. That is the standard model for enterprise legal software, but it deserves to be named for what it is: a real evaluation cost. You cannot budget for Supio from public information, and you cannot compare it on price against alternatives without running parallel sales processes.

Third-party sites publish estimates — one competitor’s buying guide, ProPlaintiff’s Supio pricing guide, suggests platforms in this class typically run in the low hundreds of dollars per user per month before volume-based document processing — but Supio has confirmed none of these figures, the source has an obvious competitive interest, and we could not verify any number independently. Treat everything outside a written quote as unverified. The table below describes how the pricing is structured, not what it costs.

Verified against supio.com on July 4, 2026: no public pricing exists. Any dollar figure you encounter for Supio outside a written quote is a third-party estimate the vendor has not confirmed.

Detailed feature review

Supio Agent: the firm-wide layer

Supio’s newest and most ambitious piece is Supio Agent, which the company calls the first agentic AI platform for plaintiff law. The distinction it draws against task tools is architectural: rather than answering one prompt about one uploaded document, the agent connects to the systems the firm already runs — case management, records repositories, intake, email — and works across every case with the full context of the practice. The vendor’s claim is that it builds institutional memory: it learns the firm’s templates, tone, attorney styles and outcomes, and applies them automatically, so the platform’s output improves the longer the firm uses it. That is a compelling pitch and a hard one to verify from outside; buyers should test it directly by asking, in a pilot, whether month-three output on their own matters is measurably better than month one.

Medical chronologies (MedChrons)

The MedChron is PI law’s most brutal grunt work: reducing thousands of pages of medical records into an accurate, dated narrative of injury and treatment. This is Supio’s foundation product. The platform reads complete record sets, assembles a chronological account, and — per the vendor — surfaces connections a rushed human reviewer misses: symptoms that suggest undiagnosed injuries, treatment gaps that the defense will exploit, inconsistencies between providers. Because every entry links to its source page, the paralegal’s job shifts from assembling the chronology to verifying it. One vendor case study reports paralegals at J. Chrisp Law reclaiming roughly 80 hours per case on chronology work; that is Supio’s number, not ours, but the direction of the saving is plausible given what the task costs manually.

AI demand letters

The demand product generates settlement demand packages grounded in the case file, with what Supio calls human-verified accuracy: purpose-built AI trained on personal-injury data, every claim linked to source documents, and the ability to distinguish documented fact from provider opinion in the records. Supio also emphasizes unlimited editing without per-revision fees — a pointed jab at per-document pricing models in this category — and integration with the firm’s case management system so demands are produced inside existing workflow rather than around it. For most PI firms the demand is the single highest-leverage document in the case, which is why demand quality, not raw speed, is the thing to test in an evaluation: put a Supio demand next to your best paralegal’s on the same closed file and judge which one you would send.

Case Ledger and case economics

Supio’s case-economics product tracks the financial skeleton of the case: medical bills, liens, costs and the arithmetic that determines what a settlement is actually worth to the client. In a practice where fee capture and lien resolution decide profitability, an accurate, continuously updated ledger is quietly one of the most valuable things software can provide, and it is a piece most demand-focused rivals do not carry.

Litigation drafting and deposition analysis

Beyond pre-litigation, Supio’s drafting suite extends into litigation itself: complaints, disclosures, deposition notices, interrogatories, requests for production, expert outlines and motions, accelerated by a prompt library and grounded in the case record with source-linked output. The company’s deposition tooling builds prep packages that establish causation and separate evidence from interpretation, and its deposition analysis reads transcripts to spot contradictions and proof points. This litigation depth is a real dividing line in the vertical: it moves Supio from a pre-litigation document shop toward a platform a firm can use through trial preparation.

Intake

Supio Intake applies the same machinery at the top of the funnel — evaluating and converting prospective cases without adding staff. For high-volume firms, intake quality is a portfolio decision: signing the right cases and declining the wrong ones is worth more than any efficiency downstream, so an AI layer that consistently extracts the facts that predict case value from intake materials is strategically interesting, provided the firm keeps human judgment on the accept/decline call.

Mass torts, firm intelligence and cross-case analysis

At the docket level, Supio offers mass-tort tooling and firm-wide analytics: cross-case analysis that finds patterns across an inventory, and firm intelligence that gives leadership visibility into case quality, throughput and fee capture. In mass torts — where a firm may hold thousands of similar claims and the economics turn on triaging them correctly — this kind of cross-matter machine reading is arguably the strongest use case for AI in plaintiff law, and it is a capability that single-case tools structurally cannot offer.

The Westlaw connection and the Thomson Reuters relationship

Supio states that it is “the only agentic platform for plaintiff law connected to Thomson Reuters Westlaw Advantage” — meaning its outputs can be grounded in the same authoritative case law judges and opposing counsel rely on, rather than in a model’s recollection of the law. The relationship runs deeper than an API deal: Thomson Reuters Ventures invested in Supio’s Series B, and the two companies announced a formal partnership to bring AI case-preparation tools to U.S. personal-injury firms. For buyers, the practical benefit is verifiability: research woven into drafts with citations that can be checked in Westlaw. The strategic angle is worth noting too — alignment with the incumbent legal-research giant is both a moat and a dependency, and firms standardized on Lexis should ask what the experience looks like without Westlaw. Our Lexis+ AI vs Westlaw AI comparison covers that research layer directly.

Security, privilege and compliance

PI case files are stuffed with protected health information, so security posture is not a checkbox here — it is admissibility of the whole idea. Supio’s published position is a closed system: HIPAA-compliant, with SOC 2 Type II, PHIPA and GDPR coverage listed on its security page, where client data never touches a public model and is never used to train foundation models, and every output traces to its source so an attorney can stand behind any fact in court. These are the vendor’s claims, and they are the right claims to make; a diligent firm will still verify them — request the SOC 2 report, review the data-processing terms, confirm where data is hosted and how deletion works, and get the no-training commitment in the contract. Nothing we found contradicts Supio’s posture, but on privilege and PHI, paper beats promises.

Integrations

Supio lists integrations with Thomson Reuters Westlaw and the case-management systems that dominate plaintiff practice — Litify, MyCase and CasePeer among them — and describes connecting to case management, records, intake and inbox so that documents flow in without file-picking or manual uploads. That last detail matters more than the logo wall: the difference between a platform that continuously sees the live case file and a tool you feed PDFs is the difference between an agent and a converter. During evaluation, confirm the depth of the integration with your specific stack — whether sync is two-way, what happens to work product (does the finished demand land back in the case file automatically?), and how records-retrieval services plug in.

Use cases

• Medical chronologies at scale: converting complete record sets into source-cited MedChrons in a fraction of manual time.
• Demand generation: producing settlement demand packages grounded in the file, with human verification.
• Case economics: maintaining an accurate ledger of bills, liens and costs across the caseload.
• Litigation drafting: complaints, discovery documents, motions and deposition prep built from the case record.
• Intake triage: evaluating prospective cases consistently before the firm commits.
• Mass-tort inventory analysis: cross-case pattern finding and triage across thousands of similar claims.

Who should use Supio — and who should skip it

Use it if you run a plaintiff personal-injury or mass-tort practice with real document volume — a firm producing demands weekly, drowning paralegals in records review, or holding a mass-tort inventory that needs machine-scale triage. The platform’s economics track caseload: the more records and demands flowing through the firm, the more hours the automation returns, and the firm-memory pitch only compounds where there are enough matters for patterns to emerge. Firms already on Litify, MyCase or CasePeer, or standardized on Westlaw for research, will land closest to the integrated experience Supio sells.

Skip it if you are outside plaintiff law — defense firms, corporate legal departments and general practices are simply not the customer, and generalist platforms like Harvey or CoCounsel fit better. A solo or very small PI practice with a handful of active matters should scrutinize whether a custom-quoted enterprise platform beats lighter per-document services, and any firm that cannot commit to verifying AI output before filing should not deploy this category of software at all. Buyers who need public pricing to shortlist vendors will find the demo-first motion frustrating by design.

Vendor-reported results — and how to read them

Supio’s marketing leans hard on outcome numbers, and honesty requires labeling them for what they are: vendor-selected case studies, not independent measurements. The Series B announcement reports Thomas Law Offices increasing annual case volume 62% after adopting Supio, and credits the platform with supporting TorHoerman Law in litigation that produced a $495 million verdict against Abbott Laboratories; the Why Supio page cites a Colorado firm turning a $700,000 offer into a $3 million result. None of these are audited, the counterfactual is unknowable, and firms that adopt cutting-edge tooling early are unusual firms to begin with. What the claims do establish is real deployment at named, verifiable firms — Supio’s customer wall includes The Cochran Firm, Daniel Stark, TorHoerman Law and Michigan Auto Law — and a vendor confident enough to attach client names to outcomes. Use the case studies as a reference list to call, not as an ROI forecast; the same press release reports Supio growing annual recurring revenue four-fold since its Series A, which says at least that a large number of PI firms looked closely and signed.

Total cost of ownership and ROI

Because Supio is custom-quoted, total cost of ownership starts opaque — but the structure of the return is clear. The savings are labor: chronology and demand production are measured in paralegal-days per case, and if the platform reliably converts those to hours-plus-verification, the arithmetic works at surprisingly modest caseloads. The upside beyond savings is case value: catching an undiagnosed injury, a treatment gap or a missed lien changes settlement outcomes in a way that dwarfs the software bill, which is exactly why Supio markets on settlements rather than hours. The costs beyond the license are the usual enterprise ones — integration with your case-management system, migrating live matters, training staff to verify rather than assemble, and the governance work of deciding what may leave the building. The honest evaluation is a paid or free pilot on five to ten closed cases: compare Supio’s chronology and demand against what the firm actually produced, count the errors in both directions, and time the verification burden. If the output survives that test, the quote is probably worth paying; if it does not, no discount makes it worthwhile.

How Supio compares to the alternatives

Inside the PI vertical, the defining matchup is Supio versus EvenUp. EvenUp built the category around the demand package and has expanded toward claims intelligence; Supio’s counter-positioning is breadth and architecture — an end-to-end platform spanning intake through litigation with a firm-wide agent layer and a Westlaw research spine, against what it characterizes (in its own comparison marketing, which you should read as advocacy) as task-scoped document generation. Neither publishes pricing, both claim accuracy through human review, and both are well funded; the only comparison that matters is a head-to-head pilot on your own closed files. Against the generalist platforms — Harvey, CoCounsel, Legora — the trade is specialization versus range: the generalists serve any practice area and win in large-firm and in-house settings, but none of them ships a MedChron engine, a demand product or PI case economics. Our Harvey vs CoCounsel comparison maps that generalist tier. And against doing nothing, the relevant baseline is outsourced chronology services and manual paralegal work — slower and unglamorous, but with well-understood costs and no new vendor risk. A PI firm in 2026 should be evaluating this category seriously; whether it lands on Supio depends on module fit, integration depth and the quote.

How we scored Supio

Our 8.1/10 is a weighted editorial assessment across the six dimensions in the scorecard, per our methodology. Supio scores highest on features and vertical depth — no platform we have reviewed covers more of the plaintiff-law case lifecycle — and on an integration story anchored by Westlaw and the major PI case-management systems. It loses points on pricing transparency (none exists), on the unverifiability of its headline outcome claims, and on total addressable fit: this is a superb tool for exactly one kind of law firm. We attach no user-review rating; we publish aggregate user scores only once enough verified practitioner submissions exist for an agent, and the editorial score above is opinion, not measurement.

Getting started with Supio

The path in is a demo, and the way to make that demo useful is to arrive with your own test. Before booking, pull three to five closed cases with complete files — ideally ones where the firm knows, with hindsight, what the records contained and what the case settled for. Ask Supio to run its chronology and demand products against those files during evaluation, then have the paralegals who worked the originals grade the output: what did it catch, what did it miss, what did it get wrong, and how long did verification take? Push on integration specifics with your actual case-management system, get the security documentation and no-training commitment in writing, and ask for reference calls with firms of your size and mix — the customer wall gives you names to request. Firms that succeed with this category treat it as a workflow change with training and QA baked in, not a tool licence; the firms that struggle buy the demo and bolt it onto unchanged process, then blame the software when nobody verifies its output.

Verdict

Supio is the most complete AI platform we have seen for plaintiff personal-injury and mass-tort law, and its thesis — that PI firms need a single agentic system spanning intake to verdict, not a drawer of task tools — is the right read of where legal AI is going in 2026. The medical-record intelligence, source-cited drafting and Westlaw connection are genuine differentiators; the funding, Thomson Reuters relationship and named customer base make it a credible long-term bet rather than a startup gamble. The honest caveats: pricing is entirely opaque, the marquee outcome numbers are vendor-reported and unverifiable, and the product is meaningless outside its vertical. For a plaintiff firm with the caseload to feed it, Supio earns its 8.1/10 and a place on any 2026 shortlist — alongside EvenUp, and settled by a pilot on your own files, not by either vendor’s marketing.

The 2026 context: agentic AI comes for the case file

Supio’s rise tracks a structural shift in legal AI. The first generation of tools answered questions and drafted paragraphs; the current generation connects to the systems where legal work actually lives and operates across them — what the industry, Supio included, now calls agentic AI. Plaintiff law is a natural first vertical for that shift because the work is unusually machine-shaped: enormous document volumes, repeatable work products, and outcomes measured in dollars that make ROI arguments concrete. It is also a market where the buyers are businesses as much as law practices — contingency-fee firms live and die on throughput and case selection, so software that credibly raises either finds budget fast. That is why the vertical drew two heavily funded specialists in Supio and EvenUp, why Thomson Reuters chose to invest rather than merely license, and why the competitive comparison pages both vendors publish about each other have become a small genre of their own. For buyers the context cuts two ways: the pace of investment means the platforms improve quarterly, and it also means claims run ahead of verification. The discipline that serves a firm here is the same one this category demands of its own outputs — trust nothing you have not traced to a source.

A practical buyer’s checklist

Before signing with Supio, a firm should be able to answer these. Does your caseload volume justify a platform — are chronologies and demands a weekly production line, or an occasional task? Which modules do you actually need on day one, and what does the quote look like with only those? How deep is the integration with your specific case-management system — two-way sync or document pull — and who owns making it work? Have you run a pilot on closed files and had the people who worked those cases grade the output for omissions and errors, not just speed? Is the verification workflow defined — who checks every AI-produced document before it leaves the firm, and is that time budgeted? Do you have the security paperwork — SOC 2 report, data-processing agreement, contractual no-training commitment — rather than the website’s assurances? And have you called two reference firms of your size from Supio’s customer list and asked what surprised them after month three? A firm that can answer all of these is buying a platform; one that cannot is buying a demo.

What Supio changes for paralegals and case staff

The least-discussed dimension of this category is what it does to the people who currently produce the work. A MedChron engine does not make the PI paralegal obsolete; it inverts the job from assembly to audit. Reading a thousand pages to build a chronology is different work from checking a machine-built chronology against the record, and firms that manage the transition deliberately — retraining staff as verifiers and case analysts, redirecting reclaimed hours into case development and client contact — report the change as a capacity gain rather than a headcount cut. Firms that skip the transition get the failure mode this category is famous for: unverified AI output flowing into demands and filings under deadline pressure. Supio’s human-verification layer mitigates this but does not remove the firm’s own duty; under every state’s professional-conduct rules, the lawyer signs the document, not the model. Budget the training time, write the QA step into the workflow, and the platform’s hours become real; skip it, and the time saved is borrowed against the first bad filing.

Editorial scorecard

Pros and cons

Alternatives to Supio

Frequently Asked Questions